BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26382779)

  • 1. Re: 18F-FDG PET/CT Impact on Testicular Tumours Clinical Management.
    Richie JP
    J Urol; 2015 Oct; 194(4):991. PubMed ID: 26382779
    [No Abstract]   [Full Text] [Related]  

  • 2. 18F-FDG PET/CT impact on testicular tumours clinical management.
    Ambrosini V; Zucchini G; Nicolini S; Berselli A; Nanni C; Allegri V; Martoni A; Rubello D; Cricca A; Fanti S
    Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):668-73. PubMed ID: 24265073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can we rely on PET in the follow-up of advanced seminoma patients?
    Siekiera J; Małkowski B; Jóźwicki W; Jasiński M; Wronczewski A; Pietrzak T; Chmielowska E; Petrus A; Kamecki K; Mikołajczak W; Kraśnicki K; Chłosta P; Drewa T
    Urol Int; 2012; 88(4):405-9. PubMed ID: 22507953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of 18F-FDG-PET in patients with testicular cancer: a meta-analysis.
    Zhao JY; Ma XL; Li YY; Zhang BL; Li MM; Ma XL; Liu L
    Asian Pac J Cancer Prev; 2014; 15(8):3525-31. PubMed ID: 24870751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of 18F-FDG PET/CT in the management of testicular cancers.
    Cook GJ; Sohaib A; Huddart RA; Dearnaley DP; Horwich A; Chua S
    Nucl Med Commun; 2015 Jul; 36(7):702-8. PubMed ID: 25757201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The more you look, the more you find: challenging results on FDG-PET CT in a patient with neurofibromatosis type I.
    Schöffski P; Deroose CM; Gheysens O; Lips N; Slabbaert K; Vancleynenbreugel B; Moerman P; Peetermans WE
    BMC Med Imaging; 2014 May; 14():19. PubMed ID: 24885974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymptomatic Solitary Metastasis to the Testis From Prostate Carcinoma Detected by FDG PET/CT.
    Hsieh TC; Lin CC; Kao CH; Wu YC; Sun SS
    Clin Nucl Med; 2016 Jan; 41(1):86-7. PubMed ID: 26402135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-up.
    Conduit C; Koh TT; Hofman MS; Toner GC; Goad J; Lawrentschuk N; Tai KH; Lewin JH; Tran B
    Cancer Imaging; 2022 Oct; 22(1):58. PubMed ID: 36209121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pitfall of 18-fluorodeoxyglucose-PET in a patient with a tattoo.
    Nam H; Smith S; Laing R
    Lancet Oncol; 2007 Dec; 8(12):1147-1148. PubMed ID: 18054884
    [No Abstract]   [Full Text] [Related]  

  • 10. Serendipitous detection of testicular seminoma on F-18 FDG positron tomography.
    Ali I; Johns W; Bottger B; Gupta SM
    Clin Nucl Med; 2007 Mar; 32(3):201-2. PubMed ID: 17314595
    [No Abstract]   [Full Text] [Related]  

  • 11. False-positive finding in FDG-PET in a patient with seminoma and sarcoidosis.
    Liepe K
    Acta Clin Belg; 2015 Apr; 70(2):138-40. PubMed ID: 25409626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The GETUG SEMITEP Trial: De-escalating Chemotherapy in Good-prognosis Seminoma Based on Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Loriot Y; Texier M; Culine S; Fléchon A; Thiery-Vuillemin A; Gravis G; Geoffrois L; Chevreau C; Gross-Goupil M; Barthelemy P; Bompas E; Mahammedi H; Laguerre B; Lacourtoisie SA; Helissey C; Ladoire S; Abraham C; Massard C; Grimaldi S; Fizazi K
    Eur Urol; 2022 Aug; 82(2):172-179. PubMed ID: 35599187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False-positive fluorodeoxyglucose positron emission tomography results after chemotherapy in patients with metastatic seminoma.
    Decoene J; Winter C; Albers P
    Urol Oncol; 2015 Jan; 33(1):23.e15-23.e21. PubMed ID: 25454484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caval seminoma thrombus on FDG PET/CT.
    Koc K; Aras M; Inanir S
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):64-5. PubMed ID: 24589250
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary Testicular Serous Papillary Carcinoma With Extensive Calcification on CT and FDG PET/CT.
    Sun D; Yu R; Geng D; Chen J; Zhang L
    Clin Nucl Med; 2014 Oct; 39(10):894-7. PubMed ID: 24999690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET imaging in testicular tumours.
    Calabrò D; Telo S; Ambrosini V
    Curr Opin Urol; 2020 Sep; 30(5):665-671. PubMed ID: 32732623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET/Computed Tomography in Renal, Bladder, and Testicular Cancer.
    Bouchelouche K; Choyke PL
    PET Clin; 2015 Jul; 10(3):361-74. PubMed ID: 26099672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NUT Midline Carcinoma in Elderly Patients: Usefulness of 18F-FDG PET/CT for Treatment Assessment.
    Kawase T; Naka G; Kubota K; Sakashita B; Takeda Y
    Clin Nucl Med; 2015 Sep; 40(9):764-5. PubMed ID: 25899594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful resection of mediastinal seminoma evaluated the response to induction chemotherapy with fluorodeoxyglucose-positron emission tomography.
    Sakaguchi Y; Isowa N
    Ann Thorac Cardiovasc Surg; 2012; 18(1):45-7. PubMed ID: 21881343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late relapse of testicular seminoma in the posterior mediastinum.
    Shin DJ; Kim JS; Kim DY; Yeo JS
    Clin Imaging; 2013; 37(2):406-8. PubMed ID: 23466004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.